Status:

UNKNOWN

Amnioinfusion Initiative

Lead Sponsor:

Università degli Studi di Brescia

Collaborating Sponsors:

KU Leuven

University of Milan

Conditions:

Oligohydramnios

Eligibility:

FEMALE

18-45 years

Phase:

PHASE3

Brief Summary

The aim of this study is to compare perinatal survival in patients presenting with early spontaneous PPROM and persistent oligohydramnios, managed either conservatively or with serial amnioinfusions.

Detailed Description

Early spontaneous Preterm Premature Rupture of Membranes (PPROM) is associated with high perinatal mortality. Due to pulmonary hypoplasia and preterm delivery, mortality exceeds 60% when PPROM occurs ...

Eligibility Criteria

Inclusion

  • Patients above 18 years, who are able to consent, with
  • Singleton pregnancy
  • with a normal structural examination as much as possible;
  • At least 2 US examination after pPROM for gestational age confirmation and diagnosis of persistent oligohydramnios
  • Follow up ultrasound examinations weekly in the treatment group
  • Acceptance of randomisation and to comply with the protocol

Exclusion

  • Maternal contra-indications to intervention or prolongation of pregnancy, including severe medical conditions in pregnancy that make fetal intervention riskful;
  • Preterm labour defined as contractions \>6/hour associated with cervical changes, cervix shortened (\<15 mm at randomization),
  • Cervical cerclage in place
  • Chorioamnionitis, defined as 2 or more of the following: maternal temperature\>38 degrees, foul-smelling vaginal discharge, uterine tenderness, fetal tachycardia\>170 bpm, white blood cell count \>18,000
  • Fetal structural anomaly detected at prenatal ultrasonography, or fetal chromosomal abnormalities involving autosomes
  • Previous invasive procedure in this index pregnancy
  • Fetal condition mandating immediate delivery
  • Severe bleeding
  • Maternal HIV and HCV infection
  • Multiple gestation

Key Trial Info

Start Date :

September 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2013

Estimated Enrollment :

82 Patients enrolled

Trial Details

Trial ID

NCT00787163

Start Date

September 1 2008

End Date

December 1 2013

Last Update

January 22 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Milano Bicocca, Ospedale san Gerardo Monza

Monza, Milano, Italy, 20052